Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance.

RATIONALE Airway obstruction in patients with asthma is associated with airway dysfunction and inflammation. Objective measurements including sputum analysis can guide therapy, but this is often not possible in typical clinical settings. Metabolomics is the study of molecules generated by metabolic pathways. We hypothesize that airway dysfunction and inflammation in an animal model of asthma would produce unique patterns of urine metabolites measured by multivariate statistical analysis of high-resolution proton nuclear magnetic resonance ((1)H NMR) spectroscopy data. OBJECTIVES To develop a noninvasive means of monitoring asthma status by metabolomics and urine sampling. METHODS Five groups of guinea pigs were studied: control, control treated with dexamethasone, sensitized (ovalbumin, administered intraperitoneally), sensitized and challenged (ovalbumin, administered intraperitoneally, plus ovalbumin aerosol), and sensitized-challenged with dexamethasone. Airway hyperreactivity (AHR) to histamine (administered intravenously) and inflammation were measured. Multivariate statistical analysis of NMR spectra based on a library of known urine metabolites was performed by partial least-squares discriminant analysis. In addition, the raw NMR spectra exported as xy-trace data underwent linear discriminant analysis. MEASUREMENTS AND MAIN RESULTS Challenged guinea pigs developed AHR and increased inflammation compared with sensitized or control animals. Dexamethasone significantly improved AHR. Using concentration differences in metabolites, partial least-squares discriminant analysis could discriminate challenged animals with 90% accuracy. Using only three or four regions of the NMR spectra, linear discriminant analysis-based classification demonstrated 80-90% separation of the animal groups. CONCLUSIONS Urine metabolites correlate with airway dysfunction in an asthma model. Urine NMR analysis is a promising, noninvasive technique for monitoring asthma in humans.

[1]  A. Chang,et al.  Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. , 2009, The Cochrane database of systematic reviews.

[2]  E. Braunwald,et al.  Biomarkers in heart failure. , 2008, The New England journal of medicine.

[3]  P. J. Barnes,et al.  Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.

[4]  S. Holgate.  Epithelium dysfunction in asthma. , 2007, The Journal of allergy and clinical immunology.

[5]  N. Rabinovitch.  Urinary leukotriene E4. , 2007, Immunology and allergy clinics of North America.

[6]  E. Moilanen,et al.  c-Jun N-terminal kinase mediates constitutive human eosinophil apoptosis. , 2007, Pulmonary pharmacology & therapeutics.

[7]  Erik J. Saude,et al.  Variation of metabolites in normal human urine , 2007, Metabolomics.

[8]  Russ Greiner,et al.  Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. , 2007, Analytical chemistry.

[9]  D. Hui,et al.  Are exhaled breath condensates useful in monitoring asthma? , 2007, Current allergy and asthma reports.

[10]  Károly Héberger,et al.  Metabolomics applied to exhaled breath condensate in childhood asthma. , 2007, American journal of respiratory and critical care medicine.

[11]  C. Ferland,et al.  Modulation of eosinophil activation in vitro by a nicotinic receptor agonist , 2007, Journal of leukocyte biology.

[12]  M. Seeds,et al.  The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils. , 2007, Cellular immunology.

[13]  Brian D. Sykes,et al.  Urine stability for metabolomic studies: effects of preparation and storage , 2007, Metabolomics.

[14]  M. M. del Giudice,et al.  Probiotics in the atopic march: highlights and new insights. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[15]  D. Cockcroft,et al.  Mechanisms of airway hyperresponsiveness. , 2006, The Journal of allergy and clinical immunology.

[16]  Erik J. Saude,et al.  Optimization of NMR analysis of biological fluids for quantitative accuracy , 2006, Metabolomics.

[17]  L. D. Libera,et al.  Inflammation and perturbation of the l‐carnitine system in heart failure , 2005, European journal of heart failure.

[18]  J. Lindon,et al.  NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.

[19]  J. Griffin,et al.  Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition , 2005, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[20]  A. Gabriel,et al.  A Quantitative Method for Determining Polarization of Neutrophil Adhesion Molecules Associated with Ischemia Reperfusion , 2004, Plastic and reconstructive surgery.

[21]  Komei Ito,et al.  [Effects of dexamethasone on apoptosis of eosinophils infiltrated into bronchoalveolar lavage fluid after Sephadex bead treatment in rat]. , 2004, Arerugi = [Allergy].

[22]  Erik J. Saude,et al.  NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis , 2004, Magnetic resonance in medicine.

[23]  Richard Baumgartner,et al.  Mapping high-dimensional data onto a relative distance plane - an exact method for visualizing and characterizing high-dimensional patterns , 2004, J. Biomed. Informatics.

[24]  C. Waterfield,et al.  Phenylacetylglycine, a putative biomarker of phospholipidosis: Its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model , 2004, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[25]  Jeremy K Nicholson,et al.  NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. , 2003, Chemical research in toxicology.

[26]  A. Fryer,et al.  Dexamethasone prevents virus-induced hyperresponsiveness via multiple mechanisms. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[27]  B. Canning.  Modeling asthma and COPD in animals: a pointless exercise? , 2003, Current opinion in pharmacology.

[28]  A. Fryer,et al.  CD8+ T lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction. , 2003, American journal of respiratory and critical care medicine.

[29]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[30]  J Bruce German,et al.  Metabolomics and biochemical profiling in drug discovery and development. , 2002, Current opinion in molecular therapeutics.

[31]  J. Erjefält,et al.  Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment. , 2001, American journal of respiratory and critical care medicine.

[32]  R. Robert,et al.  Rapid diagnosis of alcoholic ketoacidosis by proton NMR , 2001, Intensive Care Medicine.

[33]  P. O'Byrne,et al.  Systemic aspects of allergic disease: bone marrow responses. , 2000, The Journal of allergy and clinical immunology.

[34]  S. Hazen,et al.  Eosinophils generate brominating oxidants in allergen-induced asthma. , 2000, The Journal of clinical investigation.

[35]  G. Gleich,et al.  Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection , 1999, The Journal of experimental medicine.

[36]  G. Gleich,et al.  Antigen-induced hyperreactivity to histamine: role of the vagus nerves and eosinophils. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[37]  A. Fryer,et al.  Muscarinic receptors and control of airway smooth muscle. , 1998, American journal of respiratory and critical care medicine.

[38]  I. Messana,et al.  Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients. , 1998, Clinical chemistry.

[39]  R L Somorjai,et al.  Near‐optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra , 1998, NMR in biomedicine.

[40]  A. Fryer,et al.  Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.

[41]  G. Gleich,et al.  Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. , 1997, The American journal of physiology.

[42]  A. J. Wilson,et al.  Eosinophil apoptosis and the resolution of airway inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[43]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[44]  K Wüthrich,et al.  A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. , 1980, Biochemical and biophysical research communications.

[45]  C. D. Fitch,et al.  A STUDY OF CREATINE METABOLISM IN DISEASES CAUSING MUSCLE WASTING. , 1964, The Journal of clinical investigation.

[46]  A. Meister,et al.  Synthesis of phenylacetylglutamine by human tissue. , 1957, The Journal of biological chemistry.

[47]  M. Hershenson,et al.  Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration. , 2008, Proceedings of the American Thoracic Society.

[48]  N. Frossard,et al.  The nerve growth factor and its receptors in airway inflammatory diseases. , 2008, Pharmacology & therapeutics.

[49]  A. Chang,et al.  Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. , 2007, The Cochrane database of systematic reviews.

[50]  I. Pavord,et al.  Biomarkers Predicting Response to Corticosteroid Therapy in Asthma , 2005, Treatments in respiratory medicine.

[51]  Murray E. Alexander,et al.  A Data-Driven, Flexible Machine Learning Strategy for the Classification of Biomedical Data , 2004, Artificial Intelligence Methods And Tools For Systems Biology.

[52]  R. Kleinpell-Nowell.  Biological Markers in Diagnosing, Monitoring, and Treating Asthma: A Focus on Noninvasive Measurements , 2004 .

[53]  Q. Hamid,et al.  Inflammatory cells in asthma: mechanisms and implications for therapy. , 2003, The Journal of allergy and clinical immunology.

[54]  Elaine Holmes,et al.  Metabonomic applications in toxicity screening and disease diagnosis. , 2002, Current topics in medicinal chemistry.

[55]  A. Fryer,et al.  Effects of dexamethasone on antigen-induced airway eosinophilia and M(2) receptor dysfunction. , 2001, American journal of respiratory and critical care medicine.

[56]  R. Porreco,et al.  Role of myoinositol in regulation of surfactant phospholipids in the newborn. , 1985, Early human development.

[57]  D. Stetten,et al.  The origin of urinary creatine in progressive muscular dystrophy. , 1955, The Journal of clinical investigation.